Overview
Browse spinoutsLegal name
SARISSA BIOMEDICAL LIMITED
Region
South East England
Registered address
Unknown
Insolvency history
Yes
Spinout
Liquidation
LTD
Company profile
Sarissa Biomedical Limited
Sarissa Biomedical For A Better World
Sarissa Biomedical Limited is a UK company with status liquidation founded in 2002 based in South East England.
CRN
04581254
Founded
2002
Age
23
Corporate ownership
Updated 06 Jun 2026 16:52
2 levels
1 ultimate controller
1
Company
Liquidation
LTD
Sarissa Biomedical Limited
CRN 04581254
2
Direct controller
Active
LTD
Mercia Fund Management Limited
CRN 06973399
3
Ultimate controller
Active
PLC
Mercia Asset Management PLC
CRN 09223445
Company events
Reference milestones and recent Companies House filing stream events.
2 events
02 Apr
2026
Gazette Dissolved Liquidation
GazetteGAZ2 | Transaction MzUxNDA5MjI2OWFkaXF6a2N4 | Paper/PDF filed
Published 03 Apr 2026 23:20
04 Nov
2002
Incorporated
InceptionCompany registered at Companies House
Spinout profile
1 entry
Company description
www.sarissa-biomedical.com A company that sells microelectrode biosensors for neurotransmitters and metabolites around the world. I am an inventor of the IP that underlies this company and founded it. Sarissa started to trade in 2005. Initially selling just biosensors for ATP, it then extended into other purines. Currently it sells biosensors for a total of 10 analytes -the most comprehensive range in the world, and has a collaborative agreement to provide biosensors for a company in the US (Pinnacle Technology).
Project impact
We have used Sarissa's technology extensively in our MRC funded projects to measure both CO2 and glucose dependent ATP release. Sarissa's technology has featured in more than 50 scientific papers, including 18 that come from commercial customers that have no link to me. Many of these papers are in high impact journals such as Nature, Science, Neuron, Nature Medicine. Sarissa has so far run 3 workshops for new and prospective customers -these last a whole day and provide hands-on training and experience of using the biosensors with a number of different in vitro preps. All of the workshops have attracted visitors from overseas including North America and the EU.
Sarissa Biomedical Ltd
2004
Public funding
3 awards
First funded
2014
Funded years
2014, 2016, 2017
Age at first award
11 years
Projects
2017
Knowledge Transfer Partnership
Aston University and Sarissa Biomedical Limited
1 Jul 2017 to 31 Aug 2019
Awarded
Unknown
To develop the capability to design, build and operate flexible, automated manufacturing technology for the volume production of In Vitro Diagnostic (IVD) Devices to address a global first to market opportunity.
2016
Small Business Research Initiative
Lead participant
PoC stroke IVD for Paramedic use
1 Mar 2016 to 30 Nov 2016
Awarded
£149,500
Total cost £149,500
Stroke affects 150,000 in the UK each year. It is the 3rd largest contributor towards premature death and the single biggest cause of acquired adult disability. The NHS currently spends £4.4bn on treating stroke patients with a further £5bn lost from the economy because one third of survivors need frequent assistance for personal care. Stroke is caused by...
2014
GRD Proof of Market
Lead participant
Market study for diagnostic biosensors
1 Oct 2014 to 31 Mar 2015
Awarded
£15,000
Total cost £25,900
Sarissa Biomedical develops & sells microelectronic (enzymatic) biosensors. Its devices are highly sensitive, selective & able to measure analytes in biological tissues & fluids such as unprocessed whole blood making them ideal for point of care diagnostics (PoC). Sarissa has identified a number of diseases where biomarkers have been proposed but the tech...
Product types
GRD Proof of Market
Knowledge Transfer Partnership
Small Business Research Initiative